Emgality

galcanezumab · Eli Lilly

Drug timelines are a Plus or Pro feature.

11 regulatory and trial events tracked for Emgality, covering 2018-09-27 to 2026-03-24. Get the full timeline:

Most recent: Clinical Trial Update: Novel Insight Into Migraine Pathophysiolgy and Galcanezumab Mechanisms of Action [Phase 4]